33 studies found for:    " February 18, 2013":" March 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention: Drug: FTC/TDF
22 Recruiting The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
Conditions: HIV;   Smoking Cessation
Interventions: Drug: Nicotine Replacement Therapy (NRT);   Drug: Varenicline;   Behavioral: HIV Tailored Quit Smoking Counseling
23 Completed THISTLE - The HIV-HCV Silibinin Trial
Conditions: HIV;   Hepatitis C
Intervention: Drug: Intravenous Silibinin (iSIL)
24 Recruiting Enhancing Quality Interventions Promoting Healthy Sexuality
Conditions: Pregnancy in Adolescence;   HIV
Interventions: Behavioral: Making Proud Choices;   Behavioral: Making Proud Choices AND Getting To Outcomes
25 Completed Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers
Condition: HIV
Intervention: Drug: Eviplera®
26 Recruiting Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV+
Intervention:
27 Recruiting Trial of Vitamin D in HIV Progression
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol);   Other: Placebo
28 Completed Biomarkers of Protocol Compliance and Product Adherence
Condition: HIV Prevention
Intervention: Other: HEC placebo gel applicators
29 Active, not recruiting In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% gel;   Drug: Vaginal product
30 Recruiting Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Condition: HIV Prevention
Interventions: Drug: TFV 1% gel;   Drug: Estradiol vaginal cream
31 Completed Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX® B/E;   Biological: Placebo for DNA/NYVAC;   Biological: Placebo for AIDSVAX(R) B/E
32 Completed Study to Evaluate a HIV Drug for the Treatment of HIV Infection
Condition: HIV-1 Infection
Interventions: Drug: BMS-955176;   Drug: Placebo matching with BMS-955176;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir;   Drug: Emtricitabine
33 Active, not recruiting Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV
Conditions: Insomnia;   Sleep Efficiency
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Behavioral Modification

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page   
Indicates status has not been verified in more than two years